Related Experiment Video
Updated: Dec 28, 2025

06:19
Integration of Animal Behavioral Assessment and Convolutional Neural Network to Study Wasabi-Alcohol Taste-Smell Interaction
Published on: August 16, 2024
767
Multiple neurotoxic items in the Chamorro diet link BMAA with ALS/PDC
Sandra Anne Banack1, Susan J Murch
1Institute for Ethnomedicine, Jackson Hole, Wyoming 83001-3464, USA. sandra@ethnomedicine.org
Summary
Beta-methyl-amino-L-alanine (BMAA) exposure, measured non-invasively via hair, may link to neurodegenerative diseases like ALS/PDC. Chronic low-level dietary BMAA exposure in the Chamorro population requires further investigation for toxicity.
Area of Science:
- Neuroscience
- Toxicology
- Environmental Health
Background:
- Beta-methyl-amino-L-alanine (BMAA) is present in the Chamorro diet on Guam, complicating dietary exposure analysis.
- Previous studies on BMAA in neurodegenerative diseases may be affected by tissue fixation methods.
Purpose of the Study:
- To investigate hair as a non-invasive biomarker for BMAA exposure.
- To assess the association between BMAA and neurodegenerative disease, specifically Amyotrophic Lateral Sclerosis/Parkinsonism-Dementia Complex (ALS/PDC).
- To evaluate the impact of tissue preservation methods on BMAA quantification in brain tissue.
Main Methods:
- Analysis of BMAA levels in hair samples as a measure of exposure.
- Comparison of BMAA concentrations in brain tissue from ALS/PDC patients and controls.
- Examination of frozen versus fixed autopsy tissues to assess BMAA degradation.
Main Results:
- BMAA was detected in brain tissues of ALS/PDC patients but not typically in controls, suggesting blood-brain barrier penetration.
- Hair analysis offers a potential non-invasive method for assessing BMAA exposure.
- Fixed autopsy tissues may underestimate BMAA concentrations compared to frozen tissues.
Conclusions:
- BMAA exposure is associated with neurodegenerative disease, potentially crossing the blood-brain barrier.
- Chronic, low-level dietary BMAA exposure in the Chamorro population warrants further research into its long-term toxicity.
- Non-invasive biomarkers like hair are crucial for understanding BMAA-related health risks.
More Related Videos
Related Concept Videos
Alzheimer's Disease: Overview
1.5K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.5K
Alzheimer's Disease: Treatment
699
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
699
Toxic Reactions: Overview
1.7K
When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
1.7K

